Applications of gene targeting technology to mental retardation and developmental disability research

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 11, Issue 4, 2005, Pages 295-302

  Pimenta, Aurea F ^b   Levitt, Pat ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b NONE

Author keywords

Conditional knock out; Cre recombinase; Inducible systems; Knock out; Mouse models

Indexed keywords

CRE RECOMBINASE;

BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; DEVELOPMENTAL DISORDER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; GENETIC MANIPULATION; GENETIC MODEL; HUMAN; HUMAN GENOME PROJECT; KNOCKOUT MOUSE; MEDICAL RESEARCH; MENTAL DEFICIENCY; METHODOLOGY; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ALLELES; ANIMALS; CHILD; DEVELOPMENTAL DISABILITIES; GENE TARGETING; HUMANS; INTEGRASES; MENTAL RETARDATION; MICE; MICE, KNOCKOUT; POINT MUTATION;

EID: 27644545357     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrdd.20084     Document Type: Review

References (61)

1. Ango F, di Cristo G, Higashiyama H, et al. 2004. Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment. Cell 119:257-272.
2. Ausubel FM, Brent R, Kingston RE, et al. 1998. Current protocols in molecular biology. New York: John Wiley & Sons.
3. Bakker CE, Verheij C, Willemsen R, et al. 1994. Fmr1 knockout mice: a model to study fragile X mental retardation-The Dutch-Belgian Fragile X Consortium. Cell 78:23-33.
4. Baquet ZC, Gorski JA, Jones KR. 2004. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24:4250-4258.
5. Branda CS, Dymecki SM. 2004. Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6:7-28.
6. Chen RZ, Akbarian S, Tudor M, et al. 2001. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327-331.
7. Copeland NG, Jenkins NA, Court DL. 2001. Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2:769-779.
8. Corbo JC, Deuel TA, Long JM, et al. 2002. Doublecortin is required in mice for lamination of the hippocampus but not the neocortex. J Neurosci 22:7548-7557.
9. Crawley JN. 1999. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835:18-26.
10. Crawley JN. 2003. Behavioral phenotyping of rodents. Comp Med 53:140-146.
11. DiLeone RJ, Marcus GA, Johnson MD, et al. 2000. Efficient studies of long-distance Bmp5 gene regulation using bacterial artificial chromosomes. Proc Natl Acad Sci USA 97:1612-1617.
12. Doetschman T, Gregg RG, Maeda N, et al. 1987. Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330:576-578.
13. Dykens EM, Hodapp RM, Finucane BM. 2000. Genetics and mental retardation syndromes. Baltimore: Paul H Brooks Publishing.
14. Festenstein R, Kioussis D. 2000. Locus control regions and epigenetic chromatin modifiers. Curr Opin Genet Dev 10:199-203.
15. γ origin of replication. Genome Res 12:1992-1998.
16. Gong S, Zheng C, Doughty ML, et al. 2003. A gene expression atlas of the CNS based on bacterial artificial chromosomes. Nature 425:917-925.
17. Gorski JA, Talley T, Qiu M, et al. 2002. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci 22:6309-6314.
18. Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
19. Gossen M, Freundlieb S, Bender G, et al. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769
20. Gross C, Zhuang X, Stark K, et al. 2002. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396-400.
21. Gu Y, Mcllwain KL, Weeber EJ, et al. 2002. Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. J Neurosci 22:2753-2763.
22. Guo H, Mao C, Jin XL, et al. 2000. Cre-mediated cerebellum- and hippocampus-restricted gene mutation in mouse brain. Biochem Biophys Res Commun 269:149-154.
23. Guy J, Hendrich B, Holmes M, et al. 2001. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322-326.
24. Hanks M, Wurst W, Anson-Cartwright L, et al. 1995. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269:679-682.
25. Heintz N. 2001. BAC to the future: the use of BAC transgenic mice for neuroscience research. Nature Rev Neurosci 2:861-870.
26. Heintz N. 2004. Gene expression nervous system atlas (GENSAT). Nat Neurosci 7:483.
27. Jaenisch R. 1976. Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus. Proc Natl Acad Sci USA 73:1260-1264.
28. Jin XL, Guo H, Mao C, et al. 2000. Emx1-specific expression of foreign genes using "knock-in" approach. Biochem Biophys Res Commun 270:978-982.
29. Kazuki Y, Schulz TC, Shinohara T, et al. 2003. A new mouse model for Down syndrome. J Neural Transm Suppl 67:1-20.
30. Kuehn MR, Bradley A, Robertson EJ, et al. 1987. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326:295-298.
31. Lander ES, Linton LM, Birren B, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
32. Lee EC, Yu D, Martinez de Velasco J, et al. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65.
33. Leighton PA, Mitchell KJ, Goodrich LV, et al. 2001. Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410:174-179.
34. Levitt P. 2003. Structural and functional maturation of the developing primate brain. Disabil Rehabil 143(4 Suppl):S35-S45.
35. Lewandoski M. 2001. Conditional control of gene expression in the mouse. Nat Rev Genet 2:743-755.
36. Li H-S, Wang D, Shen Q, et al. 2003. Inactivation of Numb and Numblike in embryonic dorsal forebrain impairs neurogenesis and disrupts cortical morphogenesis. Neuron 40:1105-1118.
37. Lichtman JW, Sanes JR. 2003. Watching the neuromuscular junction. J Neurocytol 32:767-775.
38. Lijam N, Paylor R, McDonald MP, et al. 1997. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90:895-905.
39. Meyers EN, Lewandoski M, Martin GR. 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18:136-141.
40. Mortlock DP, Guenther C, Kingsley DM. 2003. A general approach for identifying distant regulatory elements applied to the Gdf6 gene. Genome Res 13:2069-2081.
41. Murphy KC. 1998. Use of bacteriophage lambda recombination functions to promote gene replacement in Escherichia coli. J Bacteriol 180:2063-2071.
42. Muyrers JP, Zhang Y, Testa G, et al. 1999. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 27:1555-1557.
43. Nagy A. 2000. Cre recombinase: the universal reagent for genome tailoring. Genesis 26:99-109.
44. Nagy A, Gertsenstein M, Vintersten K, et al. 2003 Manipulating the mouse embryo: a laboratory manual. New York: Cold Spring Harbor Press.
45. Nagy A, Moens C, Ivanyi E, et al. 1998. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr Biol 8:661-664.
46. Olson LE, Richtsmeier JT, Leszl J, Reeves RH. 2004. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306:687-690.
47. Palmiter RD, Brinster RL. 1986. Germ-line transformation of mice. Annu Rev Genet 20:465-499.
48. Petersen PH, Zou K, Krauss S, et al. 2004. Continuing role for mouse Numb and Numb1 in maintaining progenitor cells during cortical neurogenesis. Nature Neurosci 7:803-811.
49. Reeves RH, Baxter LL, Richtsmeier JT. 2001. Too much of a good thing: mechanisms of gene action in Down syndrome. Trends Genet 17:83-88.
50. Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H. 2002. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35:243-254.
51. Skarnes WC, Moss JE, Hurtley SM, et al. 1995. Capturing genes encoding membrane and secreted proteins important for mouse development. Proc Natl Acad Sci USA 92:6592-6596.
52. Sparwasser T, Gong S, Li JY, et al. 2004. General method for the modification of different BAC types and the rapid generation of BAC transgenic mice. Genesis 38:39-50.
53. Stanford WL, Cohn JB, Cordes SP. 2001. Genetrap mutagenesis: past, present and beyond. Nat Rev Genet 2:756-768.
54. Thomas KR, Capecchi MR. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503-512.
55. Tidcombe H, Jackson-Fisher A, Mathers K, et al. 2003. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci USA 100:8281-8286.
56. van der Weyden L, Adams DJ, Bradley A. 2002. Tools for targeted manipulation of the mouse genome. Physiol Genomics 11:133-164.
57. Venter JC, Adams MD, Myers EW, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
58. Yang XW, Model P, Heintz N. 1997. Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nat Biotechnol 15:859-865.
59. Yu D, Ellis HM, Lee EC, et al. 2000. An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci USA 97:5978-5983.
60. Yu Y, Bradley A. 2001. Engineering chromosomal rearrangements in mice. Nat Rev Genet 2:780-790.
61. Zhang Y, Buchholz F, Muyrers JP, et al. 1998. A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 20:123-128.